Der anti-Transglutaminase II Antikörper CUB 7402 wird in der Literatur sehr häufig eingesetzt. Hier finden Sie eine Auswahl aktueller Veröffentlichungen:

Publikation

Anjum et al. (2009) Maternal celiac disease autoantibodies bind directly to syncytiotrophoblast and inhibit placental tissue transglutaminase activity. Reproductive Biology and Endocrinology. 7:16. »Zur Publikation

Caputo et al. (2009) Tissue transglutaminase in celiac disease: role of autoantibodies. Amino Acids. Volume 36, Issue 4, April 2009, Pages 693-699. »Zur Publikation

Kim et al. (2009) Glucosamine is an effective chemo-sensitizer via transglutaminase 2 inhibition. Cancer Letters. Volume 273, Issue 2, January 2009, Pages 243-249. »Zur Publikation

Luciani et al. (2009) SUMOylation of Tissue Transglutaminase as Link between Oxidative Stress and Inflammation. The Journal of Immunology. 183, 2775 -2784. »Zur Publikation

Park et al. (2009) Depletion of nucleophosmin via transglutaminase 2 cross-linking increases drug resistance in cancer cells. Cancer Letters. Volume 274, Issue 2, Pages 201-207. »Zur Publikation

»Sämtliche Transglutaminase II Antikörper anzeigen